- Stocks
- Healthcare
- NASDAQ: INVA

Price (delayed)

$18.15

Market cap

$1.14B

P/E Ratio

8.07

Dividend/share

N/A

EPS

$2.25

Enterprise value

$1.37B

Innoviva, Inc. is a healthcare focused asset management company. The Company intends to participate in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva operates in the United States.

Innoviva's quick ratio has soared by 71% YoY and by 30% from the previous quarter

The revenue has grown by 14% YoY and by 6% from the previous quarter

The stock's price to earnings (P/E) is 35% more than its 5-year quarterly average of 6.0 but 6% less than its last 4 quarters average of 8.6

The equity has increased by 20% year-on-year but it has declined by 5% since the previous quarter

INVA's net income is down by 38% year-on-year and by 20% since the previous quarter

The company's EPS fell by 33% YoY and by 20% QoQ

What are the main financial stats of INVA

Market
Valuations
Earnings

Shares outstanding

62.56M

Market cap

$1.14B

Enterprise value

$1.37B

Price to book (P/B)

1.7

Price to sales (P/S)

3.43

EV/EBIT

7.8

EV/EBITDA

6.36

EV/Sales

4.13

Revenue

$330.5M

EBIT

$175M

EBITDA

$214.85M

Free cash flow

$157.68M

Per share
Balance sheet
Liquidity

EPS

$2.25

Free cash flow per share

$2.52

Book value per share

$10.66

Revenue per share

$5.29

TBVPS

$15.83

Total assets

$1.22B

Total liabilities

$559.4M

Debt

$447.28M

Equity

$665.52M

Working capital

$330.07M

Debt to equity

0.67

Current ratio

12.7

Quick ratio

11.03

Net debt/EBITDA

1.07

Margins
Efficiency
Dividend

EBITDA margin

65%

Gross margin

87.1%

Net margin

44%

Operating margin

39.9%

Return on assets

11.8%

Return on equity

21.8%

Return on invested capital

14.5%

Return on capital employed

14.6%

Return on sales

53%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Innoviva stock price performed over time

Intraday

-0.71%

1 week

-0.87%

1 month

8.49%

1 year

34.44%

YTD

13.15%

QTD

10.67%

How have Innoviva's revenue and profit performed over time

Revenue

$330.5M

Gross profit

$287.74M

Operating income

$132.02M

Net income

$145.42M

Gross margin

87.1%

Net margin

44%

The operating margin has plunged by 68% YoY but it has increased by 18% from the previous quarter

INVA's operating income has shrunk by 64% YoY but it is up by 26% QoQ

The net margin has contracted by 45% YoY and by 24% from the previous quarter

INVA's net income is down by 38% year-on-year and by 20% since the previous quarter

What is Innoviva's growth rate over time

What is Innoviva stock price valuation

P/E

8.07

P/B

1.7

P/S

3.43

EV/EBIT

7.8

EV/EBITDA

6.36

EV/Sales

4.13

The stock's price to earnings (P/E) is 35% more than its 5-year quarterly average of 6.0 but 6% less than its last 4 quarters average of 8.6

The company's EPS fell by 33% YoY and by 20% QoQ

The P/B is 28% below the 5-year quarterly average of 2.4 but 23% above the last 4 quarters average of 1.4

The equity has increased by 20% year-on-year but it has declined by 5% since the previous quarter

The revenue has grown by 14% YoY and by 6% from the previous quarter

The P/S is 12% higher than the last 4 quarters average of 3.1

How efficient is Innoviva business performance

The company's return on sales has shrunk by 52% YoY and by 25% QoQ

The return on invested capital has dropped by 51% year-on-year and by 22% since the previous quarter

INVA's return on equity is down by 46% year-on-year and by 23% since the previous quarter

INVA's ROA is down by 39% YoY and by 22% from the previous quarter

What is INVA's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for INVA.

How did Innoviva financials performed over time

The total assets is 119% greater than the total liabilities

Innoviva's quick ratio has soared by 71% YoY and by 30% from the previous quarter

The company's current ratio has surged by 55% YoY and by 22% QoQ

The debt is 33% less than the equity

The equity has increased by 20% year-on-year but it has declined by 5% since the previous quarter

The debt to equity has declined by 16% year-on-year but it has grown by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.